INTRODUCTION {#sec1}
============

Industrial biotechnology can contribute to reconciliating global demands for liquid transport fuels with the almost universally accepted need to limit anthropogenic CO~2~ emissions (Fulton *et al.*[@bib26]). Bioethanol, the biofuel with the largest annual global production volume, is still predominantly produced by fermentation of sucrose or glucose, derived from sugar cane or corn starch, respectively (Gombert and van Maris [@bib31]). These 'first-generation' bioethanol processes exploit the natural high fermentation rates and ethanol yield of the yeast *Saccharomyces cerevisiae*. Optimisation of yeast strains and production processes enables many industrial processes to operate at \>90% of the theoretical ethanol yield on sugar (Basso, Basso and Nitsche Rocha [@bib7]; Gombert and van Maris [@bib31]; Lopes *et al.*[@bib54]). However, the massive scaling up of production volumes that would be required to replace a substantial fraction of petroleum-based transport fuels cannot be sustainably achieved with corn starch and cane sugar as the only feedstocks. Instead, a large fraction of the feedstock will have to be derived from lignocellulosic plant biomass, such as agricultural residues and energy crops (Lynd *et al.*[@bib55]).

In comparison with first-generation feedstocks, lignocellulosic hydrolysates pose additional challenges for yeasts and yeast researchers. In addition to containing mixtures of hexose and pentose (mainly D-xylose and L-arabinose) sugars, the deconstruction of lignocellulosic biomass that precedes yeast-based fermentation releases fermentation inhibitors (Palmqvist and Hahn-Hägerdal [@bib67]; van Maris *et al.*[@bib86]; Jansen *et al.*[@bib40]). Intensive metabolic engineering studies, encompassing functional expression of heterologous pathways for xylose and arabinose catabolism, improvements in inhibitor tolerance and minimisation of by-product formation have yielded *S. cerevisiae* strains that are now applied in the first full-scale 'second-generation' industrial bioethanol plants (Moysés *et al.*[@bib61]; Jansen *et al.*[@bib40]). However, further improvements in ethanol titres, yields and productivities are important to increase the economic viability of this nascent technology.

Current strain engineering strategies for enabling pentose fermentation by *S. cerevisiae* typically yield strains that, in anaerobic batch cultures grown on sugar mixtures, preferentially ferment glucose, while xylose and/or arabinose are predominantly converted in a second, slower fermentation phase (Jansen *et al.*[@bib40]). This strong preference for glucose over pentoses persists even after extensive laboratory evolution on sugar mixtures (Kuyper *et al.*[@bib52]; Wisselink *et al.*[@bib98]; Garcia Sanchez *et al.*[@bib28]; Shen *et al.*[@bib80]; Zhou *et al.*[@bib100]). Achieving efficient co-fermentation of glucose and pentoses, while maintaining a high overall rate of sugar conversion, could increase volumetric productivity of industrial processes. Moreover, since several inhibitors of yeast performance are more harmful during the slower pentose fermentation phase (Bellissimi *et al.*[@bib11]; Kim *et al.*[@bib44]; Ask *et al.*[@bib5]; Jansen *et al.*[@bib40]), simultaneous fermentation of glucose and pentose sugars can also contribute to robustness under industrial process conditions.

Random mutagenesis, laboratory evolution and protein engineering of xylose transporters have yielded transporter variants with improved xylose affinity and reduced glucose inhibition, which enabled the construction of yeast strains with improved xylose consumption in the presence of glucose (Farwick *et al.*[@bib25]; Nijland *et al.*[@bib64]; Reznicek *et al.*[@bib75]; Shin *et al.*[@bib81]). In an alternative approach, expression of a heterologous cellodextrin transporter and an intracellular *β*-glucosidase, along with a heterologous xylose reductase/xylitol dehydrogenase (XR/XDH) pathway, enabled simultaneous consumption of cellobiose and xylose in *S. cerevisiae* by reducing the impact of glucose repression (Wei *et al.*[@bib94]). However, despite progress in this area, engineering of yeast strains showing simultaneous, fast fermentation of glucose and xylose remains a key challenge.

Deletion of *RPE1*, which encodes the pentose-phosphate-pathway (PPP) enzyme ribulose-5-phosphate epimerase, was recently shown to result in coupling of glucose and xylose catabolism, at a ratio of 10:1, in an engineered xylose-utilising *S. cerevisiae* strain (Shen *et al.*[@bib79]). Despite a low xylose-to-glucose consumption ratio, this strategy indicated the potential of forced stoichiometric coupling of glucose and pentose metabolism in *S. cerevisiae*. In *S. cerevisiae*, phosphoglucose isomerase (Pgi1) catalyses interconversion of glucose-6-phosphate to fructose-6-phosphate in upper glycolysis (Aguilera [@bib2]). Since deletion of *PGI1* blocks glycolysis, *pgi1Δ* strains cannot grow on glucose as the sole carbon source unless all glucose-6-phosphate is rerouted through the PPP. Deletion of *eda*, *rpe* and *pgi* in *Escherichia coli* was previously shown to enable co-consumption of xylose and glucose (Gawand *et al.*[@bib29]). As conversion of 1 mol glucose-6-phosphate to 1 mol ribulose-5-phosphate via the oxidative branch of the PPP results in a net generation of 2 mol NADPH, the absence of a redox imbalance relied on conversion of excess NADPH to NADH by the native *E. coli* transhydrogenases.

Wild-type *S. cerevisiae* strains cannot reoxidise all NADPH generated by such a redirection of metabolism and, consequently, *pgi1*-null mutants cannot grow on glucose as sole carbon source (Boles, Lehnert and Zimmermann [@bib13]; Dickinson, Sobanski and Hewlins [@bib19]). Overexpression of *GDH2*, which encodes NAD^+^-dependent glutamate dehydrogenase, can restore growth of *pgi1Δ* strains by enabling a transhydrogenase-like cycle that couples the interconversion of 2-oxoglutarate and glutamate to the conversion of NADPH and NAD^+^ to NADP^+^ and NADH (Boles, Lehnert and Zimmermann [@bib13]). Based on the impact of a *pgi1Δ* mutation on glucose metabolism, we reasoned that inactivation of *PGI1* might be used to construct strains with a stringent requirement for co-utilisation of xylose and glucose, at much higher ratios than hitherto demonstrated.

The goal of this study was to explore a new strategy for identifying mutations that stimulate glucose-xylose co-consumption by *S. cerevisiae*. The strategy was based on enforcing a strict stoichiometric coupling of glucose and xylose fermentation by the combined deletion of *RPE1* and *PGI1* in an engineered, xylose-isomerase-based *S. cerevisiae* strain (Kuyper *et al.*[@bib51]; Verhoeven *et al.*[@bib90]). Furthermore, to reduce the impact of these modifications on NADP^+^/NADPH redox cofactor balancing, the native NADP^+^-dependent 6-phosphogluconate dehydrogenases (Gnd1 and Gnd2) were replaced by a heterologous NAD^+^-dependent enzyme (Papapetridis *et al.*[@bib69]). After laboratory evolution for improved growth on glucose-xylose mixtures, the physiology of evolved strains was analysed in aerobic shake-flask and bioreactor batch cultures. Potential causal mutations identified by whole-genome sequencing were introduced into a non-evolved (*PGI1 RPE1 GND1 GND2*) xylose-fermenting strain background. The resulting reverse engineered strains were then analysed in shake-flask and anaerobic bioreactor batch cultures, grown on mixtures of glucose and xylose.

MATERIALS AND METHODS {#sec2}
=====================

Maintenance of strains {#sec2-1}
----------------------

The CEN.PK lineage of *S. cerevisiae* laboratory strains (Entian and Kötter [@bib23]) was used to construct and evolve all strains used in this study (Table [1](#tbl1){ref-type="table"}, Additional File 1). Depending on strain auxotrophies, cultures were grown in YP (10 g L^−1^ yeast extract, 20 g L^−1^ peptone) (BD, Franklin Lakes, NJ) or synthetic medium (SM) (Verduyn *et al.*[@bib89]), supplemented with glucose (20 g L^−1^), xylose (20 g L^−1^), a glucose/xylose mixture (10 g L^−1^ of each sugar) or a xylose/fructose/glucose mixture (20, 10 and 1 g L^−1^ respectively). Propagation of *E. coli XL-1* Blue cultures was performed in LB medium (5 g L^−1^ Bacto yeast extract, 10 g L^−1^ Bacto tryptone, 5 g L^−1^ NaCl, 100 μg mL^−1^ ampicillin). Frozen stock cultures were stored at --80°C, after addition of glycerol (30% v/v final concentration).

###### 

Strains used in this study.

  Strain name     Relevant Genotype                                                                                                                        Origin
  --------------- ---------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------
  CEN.PK113--7D   *MATa MAL2--8c SUC2 CAN1*                                                                                                                Entian and Kötter ([@bib23])
  IMX581          *MATa ura3--52 MAL2--8c SUC2 can1::cas9-natN2*                                                                                           Mans *et al.* ([@bib57])
  IMX705          *MATa MAL2--8c SUC2 can1::cas9-natNT2 gnd2Δ gnd1::gndA*                                                                                  Papapetridis *et al.* ([@bib69])
  IMX1046         *MATa MAL2--8c SUC2 can1::cas9-natNT2 gnd2Δ gnd1::gndA gre3::ZWF1, SOL3, TKL1, TAL1, NQM1, RKI1, TKL2 sga1::9\*xylA, XKS1 rpe1Δ pgi1Δ*   This work
  IMX994          *MATa ura3--52 MAL2--8c SUC2 can1::cas9-natN2, gre3::RPE1, TKL1, TAL1, RKI1, XKS1*                                                       This work
  IMU079          *MATa ura3--52 MAL2--8c SUC2 can1::cas9-natN2, gre3::RPE1, TKL1, TAL1, RKI1, XKS1* pAKX002                                               This work
  IMX1485         *MATa ura3--52 MAL2--8c SUC2 gre3::RPE1, TKL1, TAL1, RRKI1, XKS1 hxk2Δ* pAKX002                                                          This work
  IMX1486         *MATa ura3--52 MAL2--8c SUC2 gre3::RPE1, TKL1, TAL1, RKI1, XKS1 gal83Δ* pAKX002                                                          This work
  IMX1487         *MATa ura3--52 MAL2--8c SUC2 gre3::RPE1, TKL1, TAL1, RKI1, XKS1 rsp5Δ* pAKX002                                                           This work
  IMX1488         *MATa ura3--52 MAL2--8c SUC2 gre3::RPE1, TKL1, TAL1, RKI1, XKS1 gal83::GAL83^G673T^* pAKX002                                             This work
  IMX1515         *MATa ura3--52 MAL2--8c SUC2 gre3::RPE1, TKL1, TAL1, RKI1, XKS1 rsp5Δ hxk2Δ* pAKX002                                                     This work
  IMX1583         *MATa ura3--52 MAL2--8c SUC2 gre3::RPE1, TKL1, TAL1, RKI1, XKS1 gal83::GAL83^G673T^ hxk2Δ* pAKX002                                       This work

Construction of plasmids and cassettes {#sec2-2}
--------------------------------------

PCR amplification for construction of plasmid fragments and yeast integration cassettes was performed with Phusion High Fidelity DNA Polymerase (Thermo-Scientific, Waltham, MA), according to the manufacturer\'s guidelines. Plasmid assembly was performed *in vitro* with a Gibson Assembly Cloning kit (New England Biolabs, Ipswich, MA), following the supplier\'s guidelines, or *in vivo* by transformation of plasmid fragments into yeast cells (Kuijpers *et al.*[@bib48]). For all constructs, correct assembly was confirmed by diagnostic PCR with DreamTaq polymerase (Thermo-Scientific), following the manufacturer\'s protocol. Plasmids used and constructed in this work are described in Additional File 2. All yeast genetic modifications were performed using CRISPR/Cas9-based genome editing (Mans *et al.*[@bib57]). Unique guide-RNA (gRNA) sequences targeting *GRE3*, *GAL83* and *RSP5* were selected from a publicly available list (DiCarlo *et al.*[@bib18]) and synthesised (Baseclear, Leiden, The Netherlands). Primers and oligonucleotides used in this work are listed in Additional File 3.

To construct the *GRE3*-targeting CRISPR-plasmid pUDR204, the plasmid backbone of pMEL11 was PCR amplified using primer combination 5980/5792. The insert fragment, expressing the *GRE3*-targeting gRNA, was amplified using primer combination 5979/5978 and pMEL11 as template. To construct the *RPE1*/*PGI1* double-targeting CRISPR-plasmid pUDR202, the plasmid backbone and the insert fragment were PCR amplified using primer combinations 5941/6005 and 9269/9401, respectively, using pROS11 as template. Both plasmids were assembled *in vitro* and cloned in *E. coli*. To construct CRISPR-plasmids for single deletion of *GAL83* and *RSP5*, the plasmid backbone, the *GAL83*-gRNA insert and the *RSP5*-gRNA insert were amplified using primer combination 5792/5980, 5979/11 270 and 5979/11 373, respectively, using pMEL10 as template and assembled *in vivo*.

To generate *ZWF1* and *SOL3* overexpression cassettes, promoter regions of *ADH1* and *ENO1* and the coding regions of *ZWF1* and *SOL3* (including their terminator regions) were PCR amplified using primer combinations 8956/8960, 8958/8961, 8953/8964 and 8984/8986, respectively, using CEN.PK113--7D genomic DNA as a template. The resulting products were used as templates for fusion-PCR assembly of the p*ADH1*-*ZWF1*-t*ZWF1* and p*ENO1*-*SOL3*-t*SOL3* overexpression cassettes with primer combinations 8956/8964 and 8958/8986, respectively, which yielded plasmids pUD426 and pUD427 after ligation to pJET-blunt vectors (Thermo-Scientific) and cloning in *E. coli*.

To generate yeast-integration cassettes for overexpression of the major genes of the complete PPP, p*ADH1*-*ZWF1*-t*ZWF1*, p*ENO1*-*SOL3*-t*SOL3*, p*PGK1-TKL1-*t*TKL1*, p*TEF1-TAL1-*t*TAL1*, p*PGI1-NQM1-*t*NQM1*, p*TPI1-RKI1-*t*RKI1* and p*PYK1-TKL2-*t*TKL2* cassettes were PCR amplified using primer combinations 4870/7369, 8958/3290, 3291/4068, 3274/3275, 3847/3276, 4691/3277 and 3283/3288, respectively, using plasmids pUD426, pUD427, pUD348, pUD349, pUD344, pUD345 and pUD346, respectively, as templates. To generate yeast-integration cassettes of the genes of the non-oxidative PPP, the p*TDH3*-*RPE1*-t*RPE1*, p*PGK1-TKL1-*t*TKL1*, p*TEF1-TAL1-*t*TAL1*, p*TPI1-RKI1-*t*RKI1* overexpression cassettes were PCR-amplified using primer pairs 7133/3290, 3291/4068, 3724/3725 and 10 460/10 461, respectively and plasmids pUD347, pUD348, pUD34 and pUD345 as templates.

Yeast-integration cassettes for overexpression of *Piromyces* sp. xylose isomerase (*pTPI1-xylA-tCYC1*) were PCR-amplified using primer combinations 6285/7548, 6280/6273, 6281/6270, 6282/6271, 6284/6272, 6283/6275, 6287/6276, 6288/6277 or 6289/6274, using pUD350 as template. Yeast xylulokinase overexpression cassettes (p*TEF1-XKS1-*t*XKS1*) were PCR-amplified from plasmid pUD353, using primer combination 5920/9029 or 7135/7222. A yeast-integration cassette of p*GAL83*-*gal83::GAL83^G673T^*-t*GAL83* was PCR-amplified from genomic DNA of IMS0629, using primer combination 11 273/11 274.

Strain construction {#sec2-3}
-------------------

Yeast transformation was performed as previously described (Gietz and Woods [@bib30]). Transformation mixtures were plated on SM or YP agar plates (2% Bacto Agar, BD), supplemented with the appropriate carbon sources. For transformations with the *amdS* marker cassette, agar plates were prepared and counter selection was performed as previously described (Solis-Escalante *et al.*[@bib82]). For transformations with the *URA3* selection marker counterselection was performed using 5-fluoro-orotic acid (Zymo Research, Irvine, CA), following the supplier\'s protocol. For transformations with the *hphNT* marker, agar plates were additionally supplemented with 200 mg L^−1^ hygromycin B (Invivogen, San Diego, CA) and plasmid loss was induced by cultivation in non-selective medium. After each transformation, correct genotypes were confirmed by diagnostic PCR using DreamTaq polymerase (Thermo-Scientific, see Additional File 3 for primer sequences).

Co-transformation of pUDR204 along with the p*ADH1*-*ZWF1*-t*ZWF1*, p*ENO1*-*SOL3*-t*SOL3*, p*PGK1-TKL1-*t*TKL1*, p*TEF1-TAL1-*t*TAL1*, p*PGI1-NQM1-*t*NQM1*, p*TPI1-RKI1-*t*RKI1* and p*PYK1-TKL2-*t*TKL2* integration cassettes to IMX705 (Papapetridis *et al.*[@bib69]) and subsequent plasmid counterselection yielded strain IMX963, which overexpresses the major enzymes of the PPP. Co-transformation of pUDR119, 9 copies of the *pTPI1-xylA-tCYC1* integration cassette, along with a single copy of the *pTEF1-XKS1-tXKS1*cassette, to IMX963 followed by plasmid counterselection yielded the xylose-fermenting strain IMX990. In IMX990, the *pTPI1-xylA-tCYC1* cassettes recombined *in vivo* to form a multicopy construct of xylose isomerase overexpression (Verhoeven *et al.*[@bib90]). To construct IMX1046, in which *RPE1* and *PGI1* were deleted, plasmid pUDR202 and the repair oligonucleotides 9279/9280/9281/9282 were co-transformed to IMX990. Transformation mixes of IMX1046 were plated on SM agar supplemented with a xylose/fructose/glucose mixture (20, 10 and 1 g L^−1^ final concentrations respectively), to avoid potential glucose toxicity (Boles, Lehnert and Zimmermann [@bib13]).

To construct strain IMX994, plasmid pUDE335 was co-transformed to IMX581, along with the p*TDH3*-*RPE1*-t*RPE1*, p*PGK1-TKL1-*t*TKL1*, p*TEF1-TAL1-*t*TAL1*, p*TPI1-RKI1-*t*RKI1* and *pTEF1-XKS1-tXKS1* integration cassettes, after which the CRISPR plasmid was recycled. Transformation of pAKX002 to IMX994 yielded the xylose-fermenting strain IMU079. Co-transformation of pUDE327 along with the repair oligonucleotides 5888/5889 to IMX994 yielded strain IMX1384, in which *HXK2* was deleted. Co-transformation of the pMEL10 backbone fragment, along with the *GAL83*-gRNA insert or the *RSP5*-gRNA insert and repair oligonucleotides 11 271/11 272 or 11 374/11 375, respectively, yielded strains IMX1385 (*GAL83* deletion) and IMX1442 (*RSP5* deletion). Counterselection of the CRISPR plasmids from IMX1384, IMX1385 and IMX1442 yielded, respectively, strains IMX1408, IMX1409 and IMX1451. Transformation of pAKX002 to IMX1408, IMX1409 and IMX1451 yielded the xylose-fermenting strains IMX1485, IMX1486 and IMX1487, respectively. To construct strain IMX1453, in which the mutated *GAL83^G673T^* gene replaced the wild-type *GAL83* allele, plasmid pUDR105 was co-transformed to IMX1409 with the p*GAL83*-*gal83::GAL83^G673T^*-t*GAL83* cassette. Transformation of pAKX002 to IMX1453 yielded the xylose-fermenting strain IMX1488. To construct the *hxk2Δ rsp5Δ* strain IMX1484, plasmid pUDE327 was co-transformed to IMX1451, along with the repair oligonucleotides 5888/5889. Counterselection of pUDE327 from IMX1484 yielded strain IMX1510. Transformation of pAKX002 to IMX1510 yielded the xylose-fermenting strain IMX1515. To construct the *hxk2Δ gal83::GAL83^G673T^* strain IMX1563, plasmid pUDE327 along with the repair oligonucleotides 5888/5889 was co-transformed to IMX1453. Counterselection of pUDE327 from IMX1563 yielded IMX1571. The xylose-fermenting strain IMX1583 was obtained by transformation of pAKX002 to IMX1571.

Cultivation and media {#sec2-4}
---------------------

Shake-flask growth experiments were performed in 500-mL conical shake flasks containing 100 mL of SM with urea as nitrogen source (2.3 g L^−1^ urea, 6.6 g L^−1^ K~2~SO~4~, 3 g L^−1^ KH~2~PO~4~, 1 mL L^−1^ trace elements solution (Verduyn *et al.*[@bib89]) and 1 mL L^−1^ vitamin solution (Verduyn *et al.*[@bib89])) to prevent medium acidification. The initial pH of the medium was set to 6.0 by titration with 2 mol L^−1^ KOH. Depending on the strains grown, different mixtures of carbon sources (glucose/xylose/fructose) were added and media were filter-sterilised (0.2 μm, Merck, Darmstadt, Germany). The temperature was set to 30°C and the shaking speed to 200 rpm in an Innova incubator (New Brunswick Scientific, Edison, NJ). In each case, pre-culture shake flasks were inoculated from frozen stocks. After 8--12 h of growth, exponentially growing cells from the initial shake flasks were used to inoculate fresh cultures that, after 12--18 h of growth, were used as inoculum for the growth experiments to a starting OD~660~ of 0.4--0.5 in the case of shake-flask growth experiments and of 0.2--0.3 in the case of bioreactor cultivation.

Bioreactor cultures were grown on SM (Verduyn *et al.*[@bib89]), supplemented with a glucose/xylose mixture (10 g L^−1^/20 g L^−1^ for aerobic cultivation or 20 g L^−1^/10 g L^−1^ for anaerobic cultivation). Sterilisation of the salt solution was performed by autoclaving at 121°C for 20 min. Sugar solutions were sterilised separately by autoclaving at 110°C for 20 min and added to the sterile salt media along with filter-sterilised vitamin solutions. In the case of anaerobic cultivation, media were additionally supplemented with ergosterol (10 mg L^−1^) and Tween 80 (420 mg L^−1^). Sterile antifoam C (0.2 g L^−1^; Sigma-Aldrich, St. Louis, MO) was added to all media used for bioreactor cultivation. Batch cultures were grown in 2-L bioreactors (Applikon, Delft, The Netherlands) with a 1-L working volume, stirred at 800 rpm. Culture pH was maintained at 5.0 by automatic titration with 2 mol L^−1^ KOH. Temperature was maintained at 30°C. Bioreactors were sparged at 0.5 L min^−1^ with either pressurised air (aerobic cultivation) or nitrogen gas (\<10 ppm oxygen, anaerobic cultivation). All reactors were equipped with Viton O-rings and Norprene tubing to minimise oxygen diffusion. Evaporation in bioreactor cultures was minimised by cooling the offgas outlet to 4°C.

Laboratory evolution {#sec2-5}
--------------------

Laboratory evolution of strain IMX1046 was performed via serial shake-flask cultivation on SM (Verduyn *et al.*[@bib89]). Cultures were grown in 500-mL shake flasks with 100 mL working volume. Growth conditions were the same as described above. Initially, the cultures were grown on a glucose/xylose concentration ratio of 1.0 g L^−1^/20 g L^−1^. After growth was observed, exponentially growing cells (0.05 mL of culture) were transferred to SM with a glucose/xylose concentration ratio of 2.0 g L^−1^/20 g L^−1^. During subsequent serial transfers, the glucose content was progressively increased as high growth rates were established at each sugar composition, reaching a final glucose/xylose ratio of 20 g L^−1^/20 g L^−1^, to increase the selective pressure for alleviation of glucose repression and/or inhibition of xylose conversion. At that point three single colonies were isolated from two replicate evolution experiments (IMS0628--630 and IMS0634--636, respectively) by plating on SM with 10 g L^−1^ glucose and 20 g L^−1^ xylose. This medium composition supported fast growth on plates during three consecutive restreaks.

Analytical methods {#sec2-6}
------------------

Offgas analysis, biomass dry weight measurements, HPLC analysis of culture supernatants and correction for ethanol evaporation in bioreactor experiments were performed as previously described (Papapetridis *et al.*[@bib69]). Determination of optical density was performed at 660 nm using a Jenway 7200 spectrophotometer (Cole-Palmer, Staffordshire, UK). Yields of products and biomass-specific sugar uptake rates in bioreactor batch cultures were determined as previously described (Wisselink *et al.*[@bib98]; Papapetridis *et al.*[@bib69]). All values are represented as averages ± mean deviation of independent biological duplicate cultures.

*In silico* determination of sugar uptake {#sec2-7}
-----------------------------------------

The Yeast v7.6 consensus metabolic model (Aung, Henry and Walker [@bib6]) was used for *in silico* prediction of relative xylose and glucose consumption rates in aerobic bioreactor batch cultures of strain IMS0629. The COBRA v2 toolbox (Becker *et al.*[@bib9]) was used to read the model in MATLAB vR2017b (Mathworks, Natick, MA), supported by the SBML Toolbox v4.1 and the libSBML v5.12 (Hucka *et al.*[@bib38]). The Gurobi v6.5 linear programming solver (Gurobi Optimization Inc, Houston, TX) was installed and used according to the manual provided. The MATLAB script is provided in Additional File 4.

Genome sequencing {#sec2-8}
-----------------

Genomic DNA of strains IMS0629 and IMS0634 was isolated from exponentially growing shake-flask cultures on SM (10 g L^−1^ glucose/20 g L^−1^ xylose) with a Qiagen Blood & Cell culture DNA kit (Qiagen, Germantown, MD), according to the manufacturer\'s specifications. Whole-genome sequencing was performed on an Illumina HiSeq PE150 sequencer (Novogene Company Limited, Hong Kong), as previously described (Papapetridis *et al.*[@bib68]). Sequence data were mapped to the reference CEN.PK113--7D genome (Nijkamp *et al.*[@bib62]), to which the sequences of the p*TPI1*-*gndA*-t*CYC1* and p*TPI1*-xylA-t*CYC1* cassettes were manually added. Data processing and chromosome copy number analysis were carried as previously described (Papapetridis *et al.*[@bib68]).

RESULTS {#sec3}
=======

Design of an *S. cerevisiae* strain with a forced, high stoichiometry of xylose and glucose co-consumption {#sec3-1}
----------------------------------------------------------------------------------------------------------

Design of an *S. cerevisiae* strain whose growth depended on extensive co-consumption of xylose and glucose was based on the observation that inactivation of *PGI1* blocks entry of glucose-6-phosphate into glycolysis, while inactivation of *RPE1* prevents entry of ribulose-5-phosphate into the non-oxidative PPP (Fig. [1](#fig1){ref-type="fig"}). As a consequence, a *pgi1Δ rpe1Δ* strain is unable to grow on glucose. If conversion of xylose into xylulose-5-phosphate in such a strain is enabled by expression of a heterologous xylose isomerase and overexpression of the native xylulose kinase Xks1 (Kuyper *et al.*[@bib51]), co-consumption of xylose and glucose should enable growth (Fig. [1](#fig1){ref-type="fig"}). Overexpression of native genes encoding the enzymes of the non-oxidative PPP has previously been shown to stimulate the required conversion of xylulose-5-phosphate into the glycolytic intermediates fructose-6-phosphate and glyceraldehyde-3-phosphate (Fig. [1](#fig1){ref-type="fig"}) (Johansson and Hahn-Hägerdal [@bib41]; Kuyper *et al.*[@bib51]). The predicted stoichiometry for conversion of glucose and xylose into pyruvate in a yeast strain that combines these genetic modifications is summarised in Equation 1: $$\documentclass[12pt]{minimal}
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![Schematic representation of central carbon metabolism in a yeast strain engineered for forced co-consumption of glucose and xylose. In *pgi1Δ rpe1Δ S. cerevisiae* expressing a heterologous xylose isomerase (XI, Kuyper *et al.*[@bib50]), the native 6-phosphogluconate dehydrogenases (Gnd1 and Gnd2) were replaced by a bacterial NAD^+^-dependent enzyme (GndA, Papapetridis *et al.*[@bib69]). Additionally, xylulokinase (Xks1) and enzymes of the pentose phosphate pathway (PPP) were overexpressed. F6P fructose-6-phosphate; G3P glyceraldehyde-3-phosphate; DHAP dihydroxyacetone phosphate; 6PGL 6-phosphogluconolactone; 6PG 6-phosphogluconate; RU5P ribulose-5-phosphate; XU5P xylulose-5-phosphate; R5P ribose-5-phosphate; S7P sedoheptulose-7-phosphate; E4P erythrose-4-phosphate.](foy056fig1){#fig1}

To prevent a potential excessive formation of NADPH (Boles, Lehnert and Zimmermann [@bib13]; Dickinson, Sobanski and Hewlins [@bib19]), the strain design further included replacement of the native *S. cerevisiae* NADP^+^-dependent 6-phosphogluconate dehydrogenases (Gnd1 and Gnd2) by the NAD^+^-dependent bacterial enzyme GndA (Papapetridis *et al.*[@bib69]), leading to the stoichiometry shown in Equation 2: $$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{eqnarray*} {{\rm{C}}_6}{{\rm{H}}_{12}}{{\rm{O}}_6} &+& 2\,{{\rm{C}}_5}{{\rm{H}}_{10}}{{\rm{O}}_5} + 5{\rm{ADP}} + 5{{\rm{P}}_i} + 1{\rm{NAD}}{{\rm{P}}^ + } + 6{\rm{NA}}{{\rm{D}}^ + }\nonumber\\ &\to & 5\,{{\rm{C}}_3}{{\rm{H}}_4}{{\rm{O}}_3} + 5{\rm{ATP}} + 4{{\rm{H}}_2}{\rm{O}} + {\rm{NADPH}} + 6{\rm{NADH}}\nonumber\\ &+& 7{{\rm{H}}^ + } + {\rm{C}}{{\rm{O}}_2} \end{eqnarray*}\end{document}$$

As indicated by Equation [2](#equ2){ref-type="disp-formula"}, this strain design forces co-consumption of 2 mol xylose and 1 mol glucose for the production of 5 mol pyruvate, with a concomitant formation of 1 mol NADPH, 6 mol NADH and 5 mol ATP. NADPH generated in this process can be reoxidised in biosynthetic reactions (Bruinenberg, Van Dijken and Scheffers [@bib14]) or via an L-glutamate-2-oxoglutarate transhydrogenase cycle catalysed by Gdh1 and Gdh2 (Boles, Lehnert and Zimmermann [@bib13]). Actual *in vivo* stoichiometries of mixed-sugar consumption will depend on the relative contribution of precursors derived from glucose and xylose to biomass synthesis and on the biomass yield (Verduyn *et al.*[@bib88]). In aerobic cultures, the latter strongly depends on the mode of NADH reoxidation (mitochondrial respiration, alcoholic fermentation and/or glycerol production; Bakker *et al.*[@bib6a]). While quantitation of precise co-consumption stoichiometries will therefore require experimental analysis, this strain design clearly has the potential to force xylose and glucose co-consumption at much higher stoichiometries than previously reported (Katahira *et al.*[@bib43]; Shen *et al.*[@bib80], [@bib79]; Gonçalves *et al.*[@bib32]; Nijland *et al.*[@bib64]; Westman *et al.*[@bib95]; Shin *et al.*[@bib81]).

Construction, laboratory evolution and growth stoichiometry of glucose-xylose co-consuming *S. cerevisiae* strains {#sec3-2}
------------------------------------------------------------------------------------------------------------------

To implement the proposed strain design for forced co-consumption of xylose and glucose, multiple copies of a codon-optimised expression cassette for *Piromyces xylA* (Verhoeven *et al.*[@bib90]) were integrated into the genome of *S. cerevisiae* IMX705 (*gnd1Δ gnd2Δ gndA*; Papapetridis *et al.*[@bib69]), along with overexpression cassettes for *S. cerevisiae XKS1* and for structural genes encoding PPP enzymes. Deletion of *RPE1* and *PGI1* in the resulting xylose-consuming strain IMX990 yielded strain IMX1046, which grew in aerobic shake-flask cultures on SM with 1 g L^−1^ glucose and 20 g L^−1^ xylose as sole carbon sources without a requirement for laboratory evolution. However, this strain did not grow at the same xylose concentration when the glucose concentration was increased to 10 g L^−1^. Kinetic and/or regulatory constraints in glucose-xylose co-consumption at higher glucose concentrations could, for example, reflect interference of glucose with expression or activity of Hxt transporters involved in xylose uptake.

To select for co-consumption of xylose at higher glucose concentrations, duplicate serial-transfer experiments were performed in aerobic shake-flask cultures on SM with 20 g L^−1^ xylose. During serial transfer, the glucose concentration in the medium was gradually increased from 1 to 20 g L^−1^ (Fig. [2](#fig2){ref-type="fig"}). Samples of the evolving cultures were regularly inoculated in SM containing either 20 g L^−1^ glucose or 20 g L^−1^ xylose as sole carbon source. Absence of growth on these single sugars showed that laboratory evolution did not result in an escape from their forced co-consumption. When, after 13 transfers, vigorous growth was observed on a mixture of 20 g L^−1^ glucose and 20 g L^−1^ xylose, three single-colony isolates were obtained from each laboratory evolution experiment by streaking on SM agar (10 g L^−1^ glucose/20 g L^−1^ xylose).

![Laboratory evolution of *S. cerevisiae* IMX1046 (*pgi1Δ rpe1Δ gnd1Δ gnd2Δ gndA xylA XKS1*↑ PPP↑) for improved co-consumption of xylose at high glucose concentrations. Cultures were grown in shake flasks containing 100 mL SM (pH 6) supplemented with 20 g L^−1^ xylose and progressively increasing glucose concentrations. In every transfer, 0.05 mL of an exponentially growing culture was used to inoculate the next shake flask.](foy056fig2){#fig2}

Growth studies with the six evolved isolates in shake-flask cultures on SM with 10 g L^−1^ glucose and 20 g L^−1^ xylose (Additional File 5) identified isolate IMS0629 (Evolution Line 1) as the fastest growing isolate (μ = 0.21 h^−1^). The physiology of this strain was further characterised in aerobic bioreactor batch cultures on SM containing 10 g L^−1^ glucose and 20 g L^−1^ xylose. After a ca. 10-h lag phase (Fig. [3](#fig3){ref-type="fig"}, Additional Files 6 and 7), exponential growth was observed at a specific growth rate of 0.18 h^−1^. Biomass, ethanol and CO~2~ were the main products, with additional minor formation of glycerol and acetate (Table [2](#tbl2){ref-type="table"}, Fig. [3](#fig3){ref-type="fig"}, Additional File 6). During the exponential growth phase, xylose and glucose were co-consumed at a fixed molar ratio of 1.64 mol mol^−1^ (Table [2](#tbl2){ref-type="table"}, Fig. [3](#fig3){ref-type="fig"}). Growth ceased after glucose depletion, at which point xylose consumption rates drastically decreased and corresponded to a simultaneous low rate of xylitol formation (Fig. [3](#fig3){ref-type="fig"}, Additional File 6). As previously reported for XylA-expressing, xylose-fermenting *S. cerevisiae* strains (Kuyper *et al.*[@bib51]; Verhoeven *et al.*[@bib90]), no production of xylitol was observed during the exponential growth phase. The biomass and ethanol yields on total sugars consumed were 0.28 g biomass (g sugar)^−1^ and 0.18 g ethanol (g sugar)^−1^, respectively. Together with a respiratory quotient of 1.5, these observations indicated a respiro-fermentative sugar dissimilation. In line with the inability of *pgi1Δ S. cerevisiae* to generate glucose-6-phosphate from ethanol and acetate, reconsumption of these fermentation products after glucose depletion was not coupled to growth (Fig. [3](#fig3){ref-type="fig"}, Additional File 6). However, their oxidation may have provided redox equivalents for the observed slow production of xylitol from xylose (Fig. [3](#fig3){ref-type="fig"}).

![Sugar consumption, biomass and metabolite production profiles of the evolved *S. cerevisiae* strain IMS0629 (*pgi1Δ rpe1Δ gnd1Δ gnd2Δ gndA xylA XKS1*↑ PPP↑), grown on SM with 10 g L^−1^ glucose and 20 g L^−1^ xylose in aerobic bioreactor batch cultures (pH 5, 30°C). Cultures were grown in duplicate; the data shown are from a single representative culture. **a**: filled circles glucose, open circles xylose; **b**: filled squares biomass, open squares ethanol, filled triangles acetate, open triangles glycerol, open diamonds xylitol; **c**: ratio of xylose and glucose consumption during exponential growth phase.](foy056fig3){#fig3}

###### 

Product yields, biomass-specific sugar uptake and production rates in aerobic bioreactor batch cultures of evolved strain *S. cerevisiae* IMS0629 (*pgi1Δ rpe1Δ gnd1Δ gnd2Δ gndA xylA XKS1*↑ PPP↑) on SM supplemented with 10 g L^−1^ glucose and 20 g L^−1^ xylose (pH 5, 30°C).

  ----------------------------------------------------------- --------------
  Growth rate (h^−1^)                                         0.18 ± 0.00
  Glucose-xylose consumption ratio mol mol^−1^                1.64 ± 0.00
  Spec. xylose uptake rate mmol (g biomass)^−1^ h^−1^         2.52 ± 0.00
  Spec. glucose uptake rate mmol (g biomass)^−1^ h^−1^        1.54 ± 0.07
  Spec. glycerol production rate mmol (g biomass)^−1^ h^−1^   0.23 ± 0.01
  Spec. ethanol production rate mmol (g biomass)^−1^ h^−1^    2.25 ± 0.37
  Spec. CO~2~ production rate mmol (g biomass)^−1^ h^−1^      10.43 ± 0.98
  Spec. O~2~ uptake rate mmol (g biomass)^−1^ h^−1^           6.87 ± 0.56
  Respiratory quotient                                        1.52 ± 0.03
  Biomass yield g biomass (g sugars)^−1^                      0.28 ± 0.00
  Ethanol yield g (g sugars)^−1^                              0.18 ± 0.00
  ----------------------------------------------------------- --------------

Biomass-specific rates, yields and ratios were calculated from samples taken during the mid-exponential growth phase and represent averages ± mean deviation of independent duplicate cultures. Ethanol yield was corrected for evaporation.

The quantitative data on biomass and product formation obtained from the bioreactor batch cultures enabled a comparison of the observed molar ratio of xylose and glucose consumption with a model-based prediction. To this end, the engineered metabolic network of strain IMX1046 was re-created *in silico*, using the Yeast v7.6 consensus metabolic model as a basis (Aung, Henry and Walker [@bib6]; Additional File 4). Consistent with the experimental observations on forced co-consumption, inactivation of either xylose or glucose uptake in the model network did not result in any feasible growth solutions. Using the experimentally determined average specific growth rates and oxygen consumption rates from the aerobic bioreactor batch cultures of strain IMS0629 as constraints on the model resulted in predicted xylose and glucose uptake rates of 2.68 and 1.93 mmol (g biomass)^−1^ h^−1^, respectively, corresponding to a molar ratio of the xylose and glucose consumption rates of 1.4. In view of the complexity of the model and the potential impact of differences in biomass composition, this number corresponded well with the experimentally measured value of 1.64 (Table [2](#tbl2){ref-type="table"}).

Whole-genome sequencing of evolved glucose-xylose co-consuming *S. cerevisiae* {#sec3-3}
------------------------------------------------------------------------------

To identify causal mutations for the improved growth of the evolved glucose-xylose co-consuming *S. cerevisiae* strains at high glucose concentrations, the genomes of strains IMS0629 and IMS0634 (fastest growing isolates from evolution line 1 and 2, respectively, Additional File 5) were sequenced and compared to that of their common parental strain. Despite the well-documented role of *S. cerevisiae* hexose transporters in xylose uptake (Reifenberger, Boles and Ciriacy [@bib74]; Hamacher *et al.*[@bib36]; Lee *et al.*[@bib53]; Farwick *et al.*[@bib25]), no mutations were found in the coding region of any of the 18 genes encoding these transporters (*HXT1*--*17* and *GAL2*), or in other known transporter genes. Both evolved strains harboured mutations in *HXK2* (Table [3](#tbl3){ref-type="table"}). This gene encodes the major *S. cerevisiae* hexokinase which, in addition to its catalytic role, is involved in glucose repression (De Winde *et al.*[@bib17]; Raamsdonk *et al.*[@bib72]). The mutation in IMS0629 caused a premature stop codon at position 309 of Hxk2. Both strains also harboured mutations in *RSP5*, which encodes an E3-ubiquitin ligase linked to ubiquitination and endocytosis of membrane proteins (Belgareh-Touzé *et al.*[@bib10]). In strain IMS0629, a substitution at position 686 caused a glycine to aspartic acid change at position 229 of Rsp5 (Table [3](#tbl3){ref-type="table"}). Strain IMS0634 carried a 41 bp internal deletion in *RSP5*, which included the location of the mutation in strain IMS0629 and probably caused loss of function.

###### 

Mutations identified by whole-genome sequencing of glucose-xylose co-consuming *S. cerevisiae* strains evolved for fast growth at high glucose concentrations.

  Strain and gene   Nucleotide change                    Amino acid change   Description
  ----------------- ------------------------------------ ------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **IMS0629**                                                                
  *CYC8*            G896A                                W299 →Stop          General transcriptional co-repressor; acts together with Tup1; also acts as part of a transcriptional co-activator complex that recruits the SWI/SNF and SAGA complexes to promoters; can form the prion \[OCT+\]
  *GAL83*           G673T                                D225Y               One of three possible beta-subunits of the Snf1 kinase complex; allows nuclear localisation of the Snf1 kinase complex in the presence of a non-fermentable carbon source
  *RSP5*            G686A                                G229D               NEDD4 family E3 ubiquitin ligase; regulates processes including MVB sorting, the heat shock response, transcription, endocytosis and ribosome stability; ubiquitinates Sec23, Sna3, Ste4, Nfi1, Rpo21 and Sem1; autoubiquitinates; deubiquitinated by Ubp2; regulated by SUMO ligase Siz1, in turn regulates Siz1p SUMO ligase activity; required for efficient Golgi-to-ER trafficking in COPI mutants
  *HXK2*            C927G                                Y309 →Stop          Hexokinase isoenzyme 2; phosphorylates glucose in cytosol; predominant hexokinase during growth on glucose; represses expression of *HXK1*, *GLK1*
  *RBH1*            C190A                                Q64K                Putative protein of unknown function; expression is cell-cycle regulated as shown by microarray analysis; potential regulatory target of Mbp1, which binds to the YJL181W promoter region; contains a PH-like domain
  *DCS1*            C636G                                Y212→Stop           Non-essential hydrolase involved in mRNA decapping; activates Xrn1; may function in a feedback mechanism to regulate deadenylation, contains pyrophosphatase activity and a HIT (histidine triad) motif; acts as inhibitor of neutral trehalase Nth1; required for growth on glycerol medium
  **IMS0634**                                                                
  *RSP5*            Internal deletion (41 nucleotides)   Frameshift          NEDD4 family E3 ubiquitin ligase; regulates processes including: MVB sorting, the heat shock response, transcription, endocytosis and ribosome stability; ubiquitinates Sec23, Sna3, Ste4, Nfi1, Rpo21 and Sem1; autoubiquitinates; deubiquitinated by Ubp2; regulated by SUMO ligase Siz1, in turn regulates Siz1p SUMO ligase activity; required for efficient Golgi-to-ER trafficking in COPI mutants
  *HXK2*            G1027C                               D343H               Hexokinase isoenzyme 2; phosphorylates glucose in cytosol; predominant hexokinase during growth on glucose; represses expression of *HXK1*, *GLK1*

Gene descriptions were taken from the *Saccharomyces* Genome Database (<https://www.yeastgenome.org/>, Accessed 14 December 2017).

Compared to strain IMS0634, strain IMS0629 harboured four additional nucleotide changes in protein-coding regions (Table [3](#tbl3){ref-type="table"}). A G-A change at position 896 of the transcriptional regulator gene *CYC8* introduced a stop codon at position 299 of the protein. Deletion of *CYC8* was previously shown to enhance xylose uptake in the presence of glucose, albeit at the expense of growth rate (Nijland *et al.*[@bib63]). A G-T change at position 673 of the transcriptional regulator gene *GAL83* caused an amino acid change from aspartic acid to tyrosine at position 225 of the protein. Gal83 plays a vital role in the function of the Snf1-kinase complex of *S. cerevisiae*, which is involved in activation of glucose-repressed genes in the absence of the sugar (Rahner *et al.*[@bib73]; Vincent and Carlson [@bib91], [@bib92]; Schmidt and McCartney [@bib76]).

Analysis of chromosomal copy number variations showed no chromosomal rearrangements in strain IMS0629 (Additional File 8). In contrast, strain IMS0634 carried a duplication of the right arm of chromosome 3, a duplication of the middle part of chromosome 8 and a duplication of chromosome 9 (Additional File 8). The duplications in chromosomes 8 and 9 in IMS0634 spanned the *GND1*, *GRE3* and *SGA1* loci at which the expressing cassettes for heterologous genes were integrated (Table [1](#tbl1){ref-type="table"}). In the evolved strains IMS0629 and IMS0634, *xylA* copy numbers had increased to ca. 27 and 20, respectively. This observation is consistent with previous research that showed a requirement for high copy numbers of *xylA* expression cassettes to support fast xylose consumption (Alper and Stephanopoulos [@bib4]; Verhoeven *et al.*[@bib90]). The duplication of a segment of chromosome 8 in strain IMS0634 also spanned the locations of the low-to-moderate affinity hexose transporter genes *HXT1* and *HXT5* and the high-affinity hexose transporter gene *HXT4*.

Mutations in *HXK2*, *RSP5* and *GAL83* stimulate co-consumption of xylose and glucose in aerobic cultures of xylose-consuming *S. cerevisiae* {#sec3-4}
----------------------------------------------------------------------------------------------------------------------------------------------

To investigate whether mutations acquired during evolution for forced co-consumption of glucose and xylose were relevant for mixed-sugar utilisation in a strain without forced glucose-xylose co-consumption, we focused on mutations in *HXK2* and *RSP5* (which were present in both IMS0629 and IMS0634) and/or *GAL83.* Mutations in these genes were introduced into an engineered, non-evolved xylose-consuming *S. cerevisiae* strain background (IMX994, Table [1](#tbl1){ref-type="table"}). Overexpression of *xylA* was accomplished by transforming strains with the multicopy *xylA* expression vector pAKX002 (Kuyper *et al.*[@bib50]). In aerobic shake-flask cultures grown on 10 g L^−1^ glucose and 10 g L^−1^ xylose, the reference strain IMU079 (*XKS1*↑ PPP↑ pAKX002) displayed a pronounced biphasic growth profile and only a minor co-consumption of the two sugars (0.13 mol xylose (mol glucose)^−1^; Table [4](#tbl4){ref-type="table"}, Fig. [4](#fig4){ref-type="fig"}, Additional File 9). Co-consumption was strongly enhanced in the congenic *hxk2Δ* strain IMX1485, which showed a 3-fold higher molar ratio of xylose and glucose consumption (0.41 mol mol^−1^). However, its specific growth rate before glucose depletion (0.28 h^−1^) was 13% lower than that of the reference strain (Table [4](#tbl4){ref-type="table"}). Strain IMX1487 (*rsp5Δ*), which showed a 20% lower specific growth rate than the reference strain, showed a slight improvement in co-consumption (Table [4](#tbl4){ref-type="table"}). Deletion of *GAL83* (strain IMX1486) affected neither sugar co-consumption nor growth rate. In contrast, replacement of *GAL83* by *GAL83^G673T^* (strain IMX1488) resulted in a 40% higher co-consumption of glucose and xylose than observed in the reference strain IMU079, without affecting growth rate (Table [4](#tbl4){ref-type="table"}).

![Consumption of glucose and xylose and growth of strains IMU079 (*XKS1*↑ PPP↑ pAKX002; a, d), IMX1515 (*hxk2Δ rsp5Δ XKS1*↑ PPP↑ pAKX002; b, e) and IMX1583 (*hxk2Δ gal83::GAL83^G673T^ XKS1*↑ PPP↑ pAKX002; c, f) in batch cultures. The three strains were grown on SM (urea as nitrogen source) with 10 g L^−1^ glucose and 10 g L^−1^ xylose in aerobic shake-flask cultures (pH 6, 30°C). a, b, c: filled circles glucose, open circles xylose, open squares OD~660~; d, e, f: ratio of xylose and glucose consumption during exponential growth phase. Data for independent duplicate cultures are provided in Additional File 9.](foy056fig4){#fig4}

###### 

Specific growth rates (μ) and ratio of xylose and glucose consumption in aerobic shake-flask cultures of strains IMU079 (*XKS1*↑ PPP↑ pAKX002), IMX1485 (*hkx2Δ XKS1*↑ PPP↑ pAKX002), IMX1486 (*gal83Δ XKS1*↑ PPP↑ pAKX002), IMX1487 (*rsp5Δ XKS1*↑ PPP↑ pAKX002), IMX1488 (*gal83::GAL83^G673T^ XKS1*↑ PPP↑ pAKX002), IMX1515 (*hxk2Δ rsp5Δ XKS1*↑ PPP↑ pAKX002) and IMX1583 (*hxk2Δ gal83::GAL83^G673T^ XKS1*↑ PPP↑ pAKX002) grown on SM (urea as nitrogen source) with 10 g L^−1^ glucose and 10 g L^−1^ xylose (pH 6, 30°C).

  Strain    Relevant genotype             μ (h^−1^)     Xylose-glucose consumption ratio (mol mol^−1^)
  --------- ----------------------------- ------------- ------------------------------------------------
  IMU079    *HXK2 RSP5 GAL83*             0.32 ± 0.01   0.13 ± 0.00
  IMX1485   *hxk2Δ*                       0.28 ± 0.00   0.41 ± 0.01
  IMX1486   *gal83Δ*                      0.31 ± 0.00   0.14 ± 0.01
  IMX1487   *rsp5Δ*                       0.26 ± 0.00   0.15 ± 0.00
  IMX1488   *gal83::GAL83^G673T^*         0.31 ± 0.00   0.18 ± 0.01
  IMX1515   *hxk2Δ rsp5Δ*                 0.19 ± 0.00   0.60 ± 0.00
  IMX1583   *hxk2Δ gal83::GAL83^G673T^*   0.31 ± 0.00   0.49 ± 0.00

Growth rates and ratios were calculated from samples taken during the mid-exponential growth phase and represent averages ± mean deviation of independent duplicate cultures.

Since independently evolved glucose-xylose co-consuming strains contained putative loss-of-function mutations in *HXK2* and *RSP5*, both genes were deleted in strain IMX1515 (*hxk2Δ rsp5Δ XKS1*↑ PPP↑ pAKX002). Similarly, deletion of *HXK2* and introduction of *GAL83^G673T^*were combined in strain IMX1583 (*hxk2Δ gal83::GAL83^G673T^ XKS1*↑ PPP↑ pAKX002). Co-consumption ratios in the two strains (0.60 and 0.49 mol xylose (mol glucose)^−1^, respectively) were 4- to 5-fold higher than in the reference strain IMU079 (Table [4](#tbl4){ref-type="table"}, Fig. [4](#fig4){ref-type="fig"}, Additional File 9). However, strain IMX1515 exhibited a 40% lower specific growth rate (0.19 h^−1^) than the reference strain, resulting in a 9 h extension of the fermentation experiments (Fig. [4](#fig4){ref-type="fig"}, Additional File 9). In contrast, strain IMX1583 combined a high co-consumption ratio with the same specific growth rate as that of the reference strain.

Combined mutations in *HXK2* and *GAL83* significantly accelerate conversion of glucose-xylose mixtures by anaerobic cultures of xylose-consuming *S. cerevisiae* {#sec3-5}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

To investigate the impact of the identified mutations under more industrially relevant conditions, anaerobic growth of the reference xylose-fermenting strain IMU079 (*XKS1*↑ PPP↑ pAKX002) in bioreactor batch experiments was compared with that of the two congenic double mutants IMX1515 (*hxk2Δ rsp5Δ*) and IMX1583 (*hxk2Δ gal83::*GAL83^G673T^) that showed the highest glucose-xylose co-consumption in the aerobic shake-flask experiments. The anaerobic cultures were grown on 20 g L^−1^ glucose and 10 g L^−1^ xylose to simulate the relative concentrations of these sugars typically found in corn stover and wheat straw hydrolysates (van Maris *et al.*[@bib86]).

In the anaerobic batch cultures, strains IMU079, IMX1515 and IMX1583 all produced CO~2~, biomass, ethanol and glycerol as main products, with a minor production of acetate (Table [5](#tbl5){ref-type="table"}, Fig. [5](#fig5){ref-type="fig"}, Additional File 10). The strains did not produce xylitol during exponential growth and low concentrations of xylitol in cultures of strain IMU079 (2.2 ± 0.1 mmol L^−1^) were only observed at the end of fermentation. As observed in aerobic cultures (Fig. [4](#fig4){ref-type="fig"}), strain IMU079 showed a clear biphasic growth profile in the anaerobic bioreactors (Fig. [5](#fig5){ref-type="fig"}, Additional File 10), during which a fast glucose phase (ca. 16 h) was followed by a much slower and decelerating xylose consumption phase. During the glucose phase, this reference strain maintained a specific growth rate of 0.29 h^−1^ and a glucose-xylose co-consumption ratio of 0.14 mol mol^−1^ (Table [5](#tbl5){ref-type="table"}). After a ca. 30-h lag phase (Fig. [5](#fig5){ref-type="fig"}, Additional File 10), strain IMX1515 exhibited an exponential growth rate of 0.07 ± 0.00 h^−1^, with a high glucose-xylose co-consumption ratio (0.45 ± 0.03 mol mol^−1^). Mainly as a result of its lag phase, strain IMX1515 took longer to consume all sugars than the reference strain IMU079, but its xylose-consumption phase was ca. 65% shorter (ca. 14 and 43 h, respectively; Fig. [5](#fig5){ref-type="fig"}, Additional File 10).

![Sugar consumption, biomass and metabolite production profiles of *S. cerevisiae* strains IMU079 (*XKS1*↑ PPP↑ pAKX002; a, b), IMX1515 (*hxk2Δ rsp5Δ XKS1*↑ PPP↑ pAKX002; c, d) and IMX1583 (*hxk2Δ gal83::GAL83^G673T^ XKS1*↑ PPP↑ pAKX002; e, f), grown on SM with 20 g L^−1^ glucose and 10 g L^−1^ xylose in anaerobic bioreactor batch cultures (pH 5, 30°C). Cultures were grown in duplicate, the data shown are from a single representative culture. a, c, e: filled circles glucose, open circles xylose; b, d, f: filled squares biomass, open squares ethanol, filled triangles acetate, open triangles glycerol. Data on ethanol corrected for evaporation. For duplicate cultures, refer to Additional File 10.](foy056fig5){#fig5}

###### 

Product yields, biomass-specific rates and sugar uptake ratios in anaerobic bioreactor batch cultures of strains IMU079 (*XKS1*↑ PPP↑ pAKX002), IMX1515 (*hxk2Δ rsp5Δ XKS1*↑ PPP↑ pAKX002) and IMX1583 (*hxk2Δ gal83::GAL83^G673T^ XKS1*↑ PPP↑ pAKX002) grown on SM supplemented with 20 g L^−1^ glucose and 10 g L^−1^ xylose (pH 5, 30°C).

  Strain                                                                   IMU079              IMX1515         IMX1583
  ------------------------------------------------------------------------ ------------------- --------------- -----------------------------
  Relevant genotype                                                        *HXK2 RSP5 GAL83*   *hxk2Δ rsp5Δ*   *hxk2Δ gal83::GAL83^G673T^*
  μ (h^−1^)                                                                0.29 ± 0.01         0.07 ± 0.00     0.21 ± 0.00
  Spec. xylose uptake rate mmol (g biomass)^−1^ h^−1^                      2.22 ± 0.14         2.50 ± 0.12     3.19 ± 0.02
  Spec. glucose uptake rate mmol (g biomass)^−1^ h^−1^                     15.65 ± 0.52        5.58 ± 0.08     10.09 ± 0.08
  Glucose-xylose consumption ratio (mol mol^−1^)                           0.14 ± 0.00         0.45 ± 0.03     0.32 ± 0.01
  Biomass yield on sugars (g biomass g^−1^)                                0.09 ± 0.01         0.05 ± 0.00     0.09 ± 0.00
  Ethanol yield on sugars (g g^−1^)                                        0.37 ± 0.00         0.43 ± 0.00     0.38 ± 0.01
  Glycerol yield on sugars (g g^−1^)                                       0.10 ± 0.00         0.06 ± 0.00     0.08 ± 0.00
  Ratio glycerol production on biomass production (mmol (g biomass)^−1^)   11.5 ± 0.60         12.0 ± 0.50     9.9 ± 0.10
  Xylitol production (mmol L^−1^)                                          2.22 ± 0.06         0.90 ± 0.04     0.35 ± 0.04

Rates, yields and ratios were calculated from samples taken during the mid-exponential growth phase and represent averages ± mean deviation of independent duplicate cultures. Ethanol yields were corrected for evaporation.

In contrast to strain IMX1515, strain IMX1583 (*hxk2Δ gal83::GAL83^G673T^ XKS1*↑ PPP↑ pAKX002) did not exhibit a lag phase but immediately started exponential growth at 0.21 h^−1^ (Fig. [5](#fig5){ref-type="fig"}). A comparison of biomass-specific uptake rates of xylose and glucose in the anaerobic batch experiments showed that strain IMX1583 maintained a 44% higher xylose uptake rate than strain IMU079 before glucose exhaustion (Table [5](#tbl5){ref-type="table"}). Moreover, both strains IMX1515 and IMX1583 did not show the pronounced decline of xylose consumption after glucose exhaustion that was observed in the reference strain (Fig. [5](#fig5){ref-type="fig"}, Additional File 10). As a result, the xylose consumption phase in anaerobic cultures of strain IMX1583 was 80% shorter than that strain IMU079 (ca. 9 h compared to 43 h), thereby reducing the time required for complete sugar conversion by over 24 h (Fig. [5](#fig5){ref-type="fig"}).

DISCUSSION {#sec4}
==========

Engineering *S. cerevisiae* for forced co-consumption of xylose and glucose {#sec4-1}
---------------------------------------------------------------------------

The key objective of this study was to develop and test a strain platform that, via laboratory evolution and subsequent genome resequencing, can be used to identify mutations that support co-metabolism of xylose and glucose. In previous studies, laboratory evolution of glucose-phosphorylation-negative, pentose-fermenting strains in the presence of glucose yielded valuable leads for improving utilisation of glucose-xylose mixtures, including mutations in *HXT* genes that improved pentose uptake in the presence of glucose (Farwick *et al.*[@bib25]; Nijland *et al.*[@bib64], [@bib63]; Wisselink, Van Maris and Pronk [@bib99]). The strategy described in this study differs from these previous studies as it not only enabled selection for xylose utilisation in the presence of glucose, but also for simultaneous metabolism of the two sugars. The molar ratio of xylose and glucose co-consumption (1.64 mol xylose (mol glucose)^−1^) by the evolved strain IMS0629 is the highest reported to date for batch cultures of *S. cerevisiae* (Katahira *et al.*[@bib43]; Shen *et al.*[@bib80], [@bib79]; Gonçalves *et al.*[@bib32]; Nijland *et al.*[@bib64]; Westman *et al.*[@bib95]; Shin *et al.*[@bib81]).

Inactivation of *PGI1* played a key role in forcing simultaneous utilisation of xylose and glucose (Fig. [1](#fig1){ref-type="fig"}). To pre-empt the well-documented inability of *S. cerevisiae pgi1Δ* mutants to reoxidise the NADPH that is generated when metabolism of glucose-6-phosphate is rerouted through the oxidative PPP (Boles, Lehnert and Zimmermann [@bib13]; Heux, Cadiere and Dequin [@bib37]), we replaced Gnd1 and Gnd2 with the NAD^+^-linked bacterial 6-phosphogluconate dehydrogenase GndA (Papapetridis *et al.*[@bib69]). Together with the co-consumption of xylose, via an engineered pathway that did not involve NAD(P)H generation (Fig. [1](#fig1){ref-type="fig"}), these modifications enabled the engineered strain IMX1046 to grow on mixtures of xylose and 1 g L^−1^ glucose, without the fructose supplementation that is normally required for growth of *pgi1*-null mutants on glucose (Aguilera [@bib2]; Boles, Lehnert and Zimmermann [@bib13]). The evolved strain IMS0629 consumed 8.6 mmol glucose (g biomass)^−1^ in aerobic batch cultures (Table [2](#tbl2){ref-type="table"}), which is close to the requirement of 9.3 mmol NADPH (g biomass)^−1^ for aerobic growth on glucose of wild-type *S. cerevisiae* (Bruinenberg, Van Dijken and Scheffers [@bib14]). However, since glucose-6-phosphate is a key biosynthetic precursor, not all glucose consumed by the cultures can be converted through the oxidative PPP. Additional enzymes such as NADP^+^-dependent acetaldehyde dehydrogenase Ald6 (Grabowska and Chelstowska [@bib34]; Celton *et al.*[@bib16]; Papapetridis *et al.*[@bib69]) are therefore likely to have supplemented NADPH generation via the oxidative PPP in the 'forced co-consumption' strains.

Improvement of mixed-sugar fermentation in aerobic and anaerobic cultures of xylose-fermenting *S. cerevisiae* {#sec4-2}
--------------------------------------------------------------------------------------------------------------

Mutations in *HXK2*, *RSP5* and *GAL83* were reverse engineered into a non-evolved strain (*XKS1*↑ PPP↑) to investigate whether mutations acquired during evolution of strain IMX1046 (*pgi1Δ rpe1Δ gnd1Δ gnd2Δ gndA xylA XKS1*↑ PPP↑) on glucose-xylose mixtures would also stimulate mixed-substrate utilisation in a genetic background that does not impose forced co-utilisation. During growth on glucose-xylose mixtures, the reference strain IMU079 (*XKS1*↑ PPP↑ pAKX002) displayed the typical biphasic growth profile seen in non-evolved, xylose-consuming strains that express a basic, functional xylose-isomerase (XI)-based xylose fermentation pathway (Kuyper *et al.*[@bib50], [@bib51]). Biphasic growth was especially pronounced in anaerobic cultures, in which the xylose consumption rate collapsed upon glucose depletion (Fig. [5](#fig5){ref-type="fig"}). Deletion of *HXK2*, either combined with the deletion of *RSP5* or with the introduction of a *GAL83^G673T^* mutation, strongly improved mixed-sugar fermentation kinetics, both by increased co-utilisation and by faster conversion of xylose after glucose had been depleted (Figs [4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}).

Hxk2, the major hexokinase in *S. cerevisiae*, plays an additional key role in transcriptional repression of a large set of yeast genes (Entian [@bib21]; Entian and Fröhlich [@bib22]; Peláez, Herrero and Moreno [@bib70]) by glucose. Deletion of *HXK2* has been shown to enhance co-consumption of combinations of natural substrates (glucose-galactose, glucose-sucrose and glucose-ethanol) in batch cultures (Raamsdonk *et al.*[@bib72]). During exponential growth on glucose in batch cultures, *hxk2Δ* mutants show increased transcription of the high-affinity hexose transporter genes *HXT2* and *HXT7* and decreased transcription of the low-affinity hexose transporter genes *HXT1* and *HXT3* (Petit *et al.*[@bib71]). The high-affinity Hxt transporters, which in wild-type strains are only expressed at low glucose concentrations (Diderich *et al.*[@bib20]), have a much lower K~m~ for xylose than their low-affinity counterparts (Hamacher *et al.*[@bib36]; Lee *et al.*[@bib53]). Several studies have demonstrated that overexpression of high-affinity hexose transporters stimulates xylose uptake (Subtil and Boles [@bib83]; Farwick *et al.*[@bib25]; Gonçalves *et al.*[@bib32]; Nijland *et al.*[@bib64], [@bib65]; Reznicek *et al.*[@bib75]; Shin *et al.*[@bib81]; Jansen *et al.*[@bib40]). The observed improved co-utilisation of glucose and xylose upon inactivation of *HXK2* may therefore reflect an increased abundance of high-affinity hexose transporters in the yeast plasma membrane during growth on glucose-xylose mixtures. A recent *in silico* study identified *HXK2* as potential target for improving xylose uptake rates in *S. cerevisiae* (Miskovic *et al.*[@bib59]). However, subsequent deletion of *HXK2* in a strain expressing a XR/XDH-based pathway resulted in faster xylose uptake but also increased by-product formation and reduced ethanol productivity (Miskovic *et al.*[@bib59]). The absence of such negative effects in the present study is in line with reports that XI-based strains are less prone to by-product formation than XR/XDH-based strains (Moysés *et al.*[@bib61]; Jansen *et al.*[@bib40]).

Rsp5, the only representative of the NEDD4 family of E3-ubiquitin ligases in *S. cerevisiae*, is involved in regulation of a multitude of cellular processes, including intracellular protein trafficking, regulation of the large subunit of RNA polymerase II, ribosome stability, regulation of fatty acid synthesis and stress response (Huibregtse, Yang and Beaudenon [@bib39]; Belgareh-Touzé *et al.*[@bib10]; Kaliszewski and Zoładek [@bib42]; Shcherbik and Pestov [@bib78]). This multitude of roles may explain the reduced growth rate of the *rsp5Δ* strains (Tables [4](#tbl4){ref-type="table"} and [5](#tbl5){ref-type="table"}) in this study. Involvement of Rsp5 in ubiquitination and subsequent endocytosis of the high-affinity hexose transporters Hxt6 and Hxt7 (Krampe *et al.*[@bib47]; Haguenauer-Tsapis and André [@bib35]) could explain the strong synergistic effect of the *hxk2Δ* and *rsp5Δ* deletions: while deletion of *HXK2* prevents glucose repression of the synthesis of these transporters, deletion of *RSP5* could prevent their ubiquitination and removal from the membrane. Removal of ubiquitination sites in the hexose transporters Hxt1 and Hxt36 was previously shown to enhance xylose uptake by *S. cerevisiae* (Nijland *et al.*[@bib65]). Our results suggest that a similar modification of Hxt6 and Hxt7 could also be beneficial.

Gal83 is one of three possible β-subunits of the Snf1-kinase complex, which enables transcription of glucose-repressed genes at low glucose concentrations (for reviews, see Gancedo [@bib27]; Schüller [@bib77]). At non-repressing glucose concentrations, Gal83 directs the Snf1-Gal83 complex to the cell nucleus (Vincent *et al.*[@bib93]), where it mediates transcriptional upregulation of genes involved in utilisation of alternative carbon sources (Vincent and Carlson [@bib92]). Targets of the Snf1-Gal83 complex include the *GAL* regulon (Matsumoto, Toh-e and Oshima [@bib58]; Erickson and Johnston [@bib24]) and the high-affinity hexose transporter genes *HXT2* and *HXT4* (Özcan and Johnston [@bib66]). The D225Y substitution, which stimulated glucose-xylose co-consumption in the present study, is located in the glycogen-binding domain of Gal83 (residues 161--243; Momcilovic *et al.*[@bib60]). Other mutations in this domain have been shown to cause transcription of Snf1-Gal83 targets in the presence of glucose (Wiatrowski *et al.*[@bib96]; Momcilovic *et al.*[@bib60]; Mangat *et al.*[@bib56]). In contrast to deletion of the transcriptional regulator *CYC8* (Nijland *et al.*[@bib63]), which also stimulated co-utilisation but caused severe reductions of the specific growth rate of engineered strains, the *GAL83^G673T^* mutation did not have a strong impact on growth rate (Tables [4](#tbl4){ref-type="table"} and [5](#tbl5){ref-type="table"}). The synergistic effect of the *hxk2Δ* and *GAL83^G673T^* mutations may be related to the involvement of Hxk2 in deactivation of Snf1 in the presence of glucose, causing constitutive activity of the Snf1-Gal83 complex in *hxk2*-null mutants (Gancedo [@bib27]; Schüller [@bib77]).

The reverse engineered mutations in *HXK2* and *GAL83* or *RSP5* not only stimulated simultaneous utilisation of xylose and glucose when both sugars were present, but also prevented the sharp decline in xylose uptake rates that occurred in the reference strain IMU079 (*XKS1*↑ PPP↑ pAKX002). In the reference strain, the biomass-specific rate of xylose consumption, probably mediated by low- or moderate-affinity Hxt transporters, declined to values below 0.5 mmol (g biomass)^−1^ h^−1^ after glucose depletion (Fig. [5](#fig5){ref-type="fig"}, Additional File 10). Under anaerobic conditions, this low rate of xylose fermentation would correspond to a biomass-specific rate of ATP production of 0.8 mmol (g biomass)^−1^ h^−1^. This value is lower than the estimated ATP requirement for cellular maintenance of *S. cerevisiae* (ca. 1 mmol ATP (g biomass)^−1^ h^−1^; Boender *et al.*[@bib12]). Since protein synthesis is a highly ATP-intensive process (Canelas *et al.*[@bib15]), an inability of the reference strain to functionally express high-affinity hexose transporters upon glucose depletion may therefore reflect an energy shortage. A similar effect was observed during transitions between glucose and galactose growth in anaerobic *S. cerevisiae* cultures (van den Brink *et al.*[@bib85]). By already expressing functional high-affinity transporters before glucose was depleted, the *hxk2Δ rsp5Δ* and *hxk2Δ GAL83^G673T^*genotypes may have enabled cells to avoid such a bioenergetic 'valley of death' upon the transition to xylose fermentation. In industrial processes using lignocellulosic feedstocks, this energetic challenge is likely to be even more stringent due to the presence of compounds such as acetic acid that increase maintenance energy requirements (Verduyn *et al.*[@bib89]; Abbott *et al.*[@bib1]; Bellissimi *et al.*[@bib11]).

While reverse engineering of *HXK2*, *RSP5* and *GAL83* mutations demonstrated the relevance of the forced co-utilisation strategy demonstrated in this study, they do not exhaust its possibilities. Prolongation of the evolution experiments, combined with anaerobic conditions and/or a further increase of the glucose to xylose ratio in the medium, may allow for selection of additional relevant mutations. The IMS0629 strain may also be used to select mutations that enable efficient co-utilisation of glucose and xylose at different concentrations or in lignocellulosic hydrolysates that, in addition to fermentable sugars, contain inhibitors of yeast performance (Palmqvist and Hahn-Hägerdal [@bib67]; Klinke *et al.*[@bib45]; Almeida *et al.*[@bib3]). Alternatively, the strain design can be adapted to enable selection for co-metabolism of other sugars, for example by replacing the xylose pathway by a bacterial pathway for conversion of L-arabinose into xylulose-5-phosphate (Becker and Boles [@bib8]; Wisselink *et al.*[@bib97]). This strategy can be extended to optimising the yeast metabolic network for aerobic production of economically relevant compounds other than ethanol from lignocellulosic hydrolysates. In particular, imposing fixed stoichiometries of glycolytic and (non-oxidative) PPP reactions may offer interesting options for high-yield production of compounds whose synthesis requires a large net input of PPP intermediates and/or NADPH, such as aromatic compounds and lipids (Tehlivets, Scheuringer and Kohlwein [@bib84]; Klug and Daum [@bib46]; Gottardi *et al.*[@bib33]).

CONCLUSIONS {#sec5}
===========

Engineering of carbon and redox metabolism yielded an *S. cerevisiae* strain whose growth was strictly dependent on the simultaneous uptake and metabolism of xylose and glucose. Laboratory evolution improved growth of the resulting strains on mixtures of xylose and glucose at elevated glucose concentrations. Mutations in *HXK2*, *RSP5* and *GAL83* were identified by genome sequencing of the evolved strains. Upon their combined introduction into an engineered xylose-fermenting yeast strain, these mutations strongly stimulated simultaneous utilisation of xylose and glucose and, after depletion of glucose, fast conversion of the remaining xylose. The developed strain platform and modified versions thereof can be used for identification of further metabolic engineering targets for improving the performance of yeast strains in industrial processes based on lignocellulosic feedstocks.
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